Long-term follow-up of FX Shoulder Solutions implants
Official title: RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
Run by FX Solutions · NCT07558590 · Data updated 2026-11-12
This follow-up will track adults who receive FX Shoulder Solutions hemi or total shoulder replacements to see if the implants need revision and how well shoulder function and pain hold up over 10 years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1004 (estimated) |
| Sponsor | FX Solutions Industry-sponsored |
| Locations | 22 sites (Amiens and 21 other locations) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | December 31, 2036 |
| Study ends | June 2037 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT07558590 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and over who are insured, have provided informed consent, and are indicated for hemi or total shoulder replacement with an FX Shoulder Solutions system per the device instructions are eligible.
✕Probably not a fit
Patients with neurological disorders that compromise shoulder stability, morbid obesity, or severe muscular deficiencies impairing the shoulder joint are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This post‑market program enrolls up to 1,004 cases across 11 implant groups and follows patients for 10 years after their index shoulder arthroplasty. Enrollment may be retrospective or preferably prospective, with follow-up visits at 6 weeks, 3–6 months, 1, 2, 3, 5, 7 and 10 years. The primary outcome is long‑term revision rate, and secondary outcomes include range of motion, patient‑reported scores (QuickDASH, Constant, ASES, SSV, pain), radiographic implant positioning, complication incidence, and qualitative surgeon feedback on instrumentation. Data collection is intended to reflect real‑world performance of the FX Shoulder Solutions systems.
Why it matters
Potential benefit: If successful, the results could confirm the implants' long‑term durability and safety and help surgeons choose the best replacement for patients.
How similar studies have gone: Long‑term postmarket registries and cohort studies of shoulder arthroplasty have previously produced useful revision and function data, so this approach follows established methods rather than being entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Indication for hemi or total shoulder replacement with one of the FX SHOULDER SOLUTIONS Shoulder Systems, according to its IFU and surgical technique. * Patient aged 18 years and above * Patient insured with a social security system * Has been informed and did consent to participate to the study. Exclusion Criteria: * Neurological pathologies compromising the shoulder stability * Morbid obesity * Muscular deficiencies impairing the shoulder joint
Where it's running
-
CHU Amiens Picardie
Amiens, France Recruiting -
CHU d' Angers
Angers, France Recruiting -
Hôpital Jean Minjoz
Besançon, France Recruiting -
Clinique Aguiléra
Biarritz, France Recruiting -
Hôpital privé Saint-Martin
Caen, France Recruiting -
Infirmerie Protestante
Caluire-et-Cuire, France Recruiting
Show 16 more locations
-
CHMS Chambéry
Chambéry, France Recruiting -
HÔPITAUX CIVILS de Colmar
Colmar, France Recruiting -
Hôpital privé Dijon Bourgogne
Dijon, France Recruiting -
Clinique Saint Charles
La Roche-sur-Yon, France Recruiting -
Clinique chirurgicale Porte Océane
Les Sables-d'Olonne, France Recruiting -
Clinique Saint Charles
Lyon, France Recruiting -
L'hôpital privé du confluent
Nantes, France Recruiting -
Hopital Bichat
Paris, France Recruiting -
Clinique des Maussins
Paris, France Recruiting -
Pavillon de la Mutualite
Pessac, France Recruiting -
Clinique Saint Michel et Sainte Anne
Quimper, France Recruiting -
Clinique Mutualiste
Saint-Etienne, France Recruiting -
Polyclinique de l'Atlantique
Saint-Herblain, France Recruiting -
C. H. St- Nazaire
Saint-Nazaire, France Recruiting -
Clinique de l'Orangerie
Strasbourg, France Recruiting -
Centre Hospitalier Princesse Grace
Monaco, Monaco Recruiting
Study contacts
- Study coordinator: Kathy TRIER, PhD
- Email: ktrier@fxshouldersolutions.com
- Phone: 800-280-0775
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tipmed Shoulder Prosthesis PMCF: safety and outcomes after shoulder replacement
This PMCF study tests the safety and function of the Tipmed shoulder prosthesis in adults undergoing reverse shoulder or hemiarthroplasty in real-world practice.
-
All‑polyethylene versus hybrid titanium‑pegged glenoid for stemless anatomic total shoulder replacement
This trial will test whether a cemented all‑polyethylene pegged glenoid or a hybrid trabecular titanium central‑peg glenoid gives better results for adults having a stemless anatomic total shoulder replacement for osteoarthritis.
-
Palliative and supportive care to help people with inflammatory arthritis live well
This project will see how palliative and supportive care could help adults with inflammatory arthritis live better throughout their illness.
-
HbA1c accuracy in people with inflammatory arthritis on sulfasalazine
This study tests whether HbA1c reliably reflects blood glucose in adults with inflammatory arthritis who are treated with sulfasalazine, by comparing it to continuous glucose monitoring.
-
Wearable-guided home rehabilitation after rotator cuff repair
This tests whether a wearable-device remote rehabilitation program helps adults recovering from small-to-medium rotator cuff surgery regain shoulder function better than traditional in-person rehab.
-
Joint tissue analysis to understand rare and immunotherapy-related inflammatory arthritis
This project tests whether analyzing joint biopsy tissue can reveal distinct immune features in adults with inflammatory arthritis linked to rare autoimmune diseases or caused by cancer immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.